Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
The American Journal of Clinical Nutrition|December 16, 1998
Soy intake and risk of breast cancer in Asians and Asian AmericansA H Wu, R G Ziegler, A M Nomura, et al.
Cancer|December 1, 1991
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survivalA M Levine, J Sullivan-Halley, M C Pike, et al.
British Journal of Cancer|June 1, 1996
A prospective study of urinary oestrogen excretion and breast cancer riskT J Key, D Y Wang, J B Brown, et al.
Cancer Research|November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosisM F Press, M C Pike, G Hung, et al.
Cancer Research|October 27, 1998
Androgen metabolism and prostate cancer: establishing a model of genetic susceptibilityR K Ross, M C Pike, G A Coetzee, et al.
Diabetes|September 1, 1993
North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twinD Kumar, N S Gemayel, D Deapen, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
Biochemistry|January 30, 1996
Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analoguesC K Derian, H F Solomon, J D Higgins, et al.
Leprosy Review|December 1, 1993
The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phaseJ M Pönnighaus, P E Fine, L Bliss, et al.
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Pageof 31